Continuous Acoramidis Treatment Significantly Reduced Risk Of All-cause Mortality And Cardiovascular-related Hospitalization At Month 42, In Patients With Wild-type And Variant Transthyretin Amyloidosis Cardiomyopathy

Journal of Cardiac Failure 2026

View at publisher
Authors: Martha A. Grogan, Amrut V. Ambardekar, Justin Lee Grodin, Lily Kagan Stern, Prem Soman, Marianna Fontana, Pablo García‐Pavía, Kuangnan Xiong, Suresh R Siddhanti, Jean‐François Tamby, Jonathan C. Fox, Nowell Mark Fine
+1 more Mathew S. Maurer
DOI: 10.1016/j.cardfail.2025.11.042
Cited by: 0

Fields of Study & Subjects

Amyloidosis: Diagnosis Treatment Outcomes Alzheimer's disease research and treatments Prion Diseases and Protein Misfolding

Publication details

Journal / source
Journal of Cardiac Failure
Volume
32
Issue
1
Pages
188–188
Publication date
1 January 2026
Language
EN